Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy

1. Harper, P.S. in Myotonic Dystrophy. 2nd. ed. (W.B. Saunders, 1989).
2. Howeler, C.J., Busch, H.F., Geraedts, J.P., Niermeijer, M.F. & Staal, A. Anticipation in myotonic dystrophy: Fact or fiction?. Brain 112, 779−797 (1989). | PubMed  | ISI |
3. O'Brien, T., Harper, P.S. Course, prognosis and complications of childhood-onset myotonic dystrophy. Dev. Med. Child. Neurol. 26, 62−67 (1984). | PubMed  | ChemPort |
4. Brook, J.D. et al. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68, 799−808 (1992). | Article | PubMed  | ISI | ChemPort |
5. Fu, Y.-H. et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255, 1256−1258 (1992). | PubMed  | ISI | ChemPort |
6. Mahadevan, M. et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255, 1253−1255 (1992). | PubMed  | ISI | ChemPort |
7. Harley, H. et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am. J. Hum. Genet. 52, 1164−1174 (1993). | PubMed  | ISI | ChemPort |
8. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fishbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77−79 (1991). | Article | PubMed  | ISI | ChemPort |
9. Verkerk, A.J.M.H. et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a fragile X breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65, 905−914 (1991). | PubMed  | ISI | ChemPort |
10. The Huntington's Disease Research Group. A novel gene encoding a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 72, 971−983 (1993). | PubMed  | ISI |
11. Knight, S.J. et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74, 127−134 (1993). | Article | PubMed  | ISI | ChemPort |
12. Orr, H.T. et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4, 221−226 (1993). | Article | PubMed  | ISI | ChemPort |
13. Burke, J.R. et al. The Haw River syndrome: dentatorubropallidoluysian atrophy (DRPLA) in an African-American family. Nature Genet. 7, 521−524 (1994). | Article | PubMed  | ISI | ChemPort |
14. Koide, R. et al. Unstable expansion of CAG repeat in hereditary dentatorubralpallidoluysian atrophy (DRPLA). Nature Genet. 6 1994). | PubMed  | ChemPort |
15. Nancarrow, J.K. et al. Implications of FRA 16A structure for the mechanism of chromosomal fragile site genesis. Science 264, 1938−1941 (1994). | PubMed  | ISI | ChemPort |
16. Pieretti, M. et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66, 817−822 (1991). | Article | PubMed  | ISI | ChemPort |
17. Feng, Y. et al. Translational supression by trinucleotide repeat at FMR1. Science 268, 731−734 (1995). | PubMed  | ISI | ChemPort |
18. Housman, D. Gain of glutamines, gain of function. Nature Genet. 10, 3−4 (1995). | Article | PubMed  | ISI | ChemPort |
19. Fu, Y.-H. et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260, 235−237 (1993). | PubMed  | ISI | ChemPort |
20. Sabouri, L.A. et al. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nature Genet. 4, 233−238 (1993). | Article | PubMed  | ISI | ChemPort |
21. Carango, P., Noble, J.E., Marks, H.G. & Funanage, V.L. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. Genomics 18, 340−348 (1993). | Article | PubMed  | ISI | ChemPort |
22. Hofmann-Radvanyi, H. et al. Myotonic dystrophy: Absence of CTG enlarged transcript in congenital forms and low expression of the normal allele. Hum. Mol. Genet. 2, 1263−1267 (1993). | PubMed  | ChemPort |
23. Novelli, G. et al. Failure in detecting mRNA transcripts from the mutated allele in myotonic dystrophy muscle. Biochem. Med. Metabol. Biol. 50, 85−92 (1993). | Article | ISI | ChemPort |
24. Koga, R. et al. Decreased myotonin-protein kinase in skeletal and cardiac muscles in myotonic dystrophy. Biochem. Biophys. Res. Commun. 202, 577−585 (1994). | Article | PubMed  | ISI | ChemPort |
25. Krahe, R. et al. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 28 (1995). | Article | PubMed  | ChemPort |
26. Wang, J. et al. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum. Mol. Gen. 4, 599−606 (1995). | PubMed  | ISI | ChemPort |
27. Maeda, M. et al. Identification, tissue-specific expression, and subcellular localization of the 80 and 71 kDa forms of myotonic dystrophy kinase protein. J. Biol. Chem. 270, 20246−20249 (1995). | Article | PubMed  | ISI | ChemPort |
28. Jansen, G. et al. Characterization of the myotonic dystrophy region predicts multiple protein isoform-encoding mRNAs. Nature Genet. 1, 261−266 (1992). | Article | PubMed  | ISI | ChemPort |
29. Mahadevan, M.S. et al. Structure and genomic sequence of the myotonic dystrophy (DM kinase). Gene 2, 299−304 (1993). | ChemPort |
30. Kamps, M.R., Taylor, S.S. & Sefton, B.M. Direct evidence that oncogenic tyrosine kinases and cyclic AMP-dependent protein kinases have homologous ATP binding sites. Nature 310, 589−592 (1984). | PubMed  | ISI | ChemPort |
31. Hanks, S.K., Quinn, A.M. & Hunter, T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241, 42−52 (1988). | PubMed  | ISI | ChemPort |
32. Sacco, P., Jones, D.A., Dick, J.R.T. & Vrbova, G. Contractile properties and susceptibility to exercise induced damage of normal and mdx tibialis anterior muscle. Clin. Sci. 82, 227−336 (1992). | PubMed  | ISI | ChemPort |
33. Burke, R.E. Physiology of Motor Units in Myology 2nd. ed. (eds. Andrew G. Engel & Clara Franzini-Armstrong) 1, 464−484 (McGraw-Hill Inc., New York 1994).
34. Bailce-Gordon, R.J. & Lichtman, J.W. In vivo visualization of the growth of pre and postsynaptic elements of mouse neuromuscular junctions. J. Neurosci. 10, 894−908 (1990). | PubMed  | ChemPort |
35. Wernig, A. & Herrera, A.A. Sprouting and remodelling at the nerve-muscle junction. Prog. Neurobiol. 7, 251−291 (1986). | Article |
36. Morgan-Hughes, J.A. Mitochondrial diseases in Myology 2nd. ed. (eds. Andrew G. Engel and Clara Franzini-Armstrong) 1610−1660 (McGraw-Hill Inc., New York 1994).
37. Moss, F.P. & Leblond, C.P. Satellite cells as a source of nuclei in muscles of growing rats. Anat Rec. 170, 421−436 (1970). | ISI |
38. Campion, D.R. The muscle satellite cell: A review. Int. Rev. Cytol. 87, 225−251 (1984). | PubMed  | ISI | ChemPort |
39. Grounds, M.D., Garrett, K., Lai, M.C., Wright, W.E. & Beilharz, M.W. Identification of skeletal muscle precursor cells in vivo by use of MyoD and myogenin probes. Cell Tissue Res. 267, 99−104 (1992). | PubMed  | ISI | ChemPort |
40. Koishi, K., Zhang, M., McLennan, I.S. & Haris, A.J. MyoD protein accumalates in satellite cells and is neurally regulated in regenerating myotubes and skeletal muscle fibers. Developmental Dynamics 202, 244−254 (1995). | PubMed  | ISI | ChemPort |
41. Beilharz, M.W., Lareu, R.R., Garrett, K.L., Grounds, M.D. & Fletcher, S. Quantitation of muscle precursor cell activity in skeletal muscle by northern analysis of MyoD and Myogenin expression: Application to dystrophic (mdx) mouse model. Mol. and Cell. Neurosciences 3, 326−331 (1992). | ChemPort |
42. Gambke, B. & Rubinstein, N.A. A monoclonal antibody to embryonic myosin heavy chain of rat skeletal muscle. J. Biol. Chem. 259, 12092−12100 (1984). | PubMed  | ChemPort |
43. Bancroft, J.D. & Stevens, A. Theory and Practice of Histological Techniques. (1990).
44. Casanova, G. & Jerusalem, F. Myopathology of myotonic dystrophy. A morphometric study. Acta Neuropathol 45, 231 (1979). | PubMed  | ChemPort |
45. Anderson, J.E., Ovalle, W.K. & Bressler, B.H., Electron Microscopic and Autoradiographic Characterization of Hindlimb Muscle Regeneration in mdx Mouse. Anat. Rec. 219, 243−257 (1987). | PubMed  | ISI | ChemPort |
46. Carnwath, J.W. & Shotton, D.M. Muscular dystrophy in the mdx mouse: Histopathology of the soleus and extensor digitorum longus muscles. J. Neurol. Sci. 80, 39−54 (1987). | Article | PubMed  | ISI | ChemPort |
47. Fitzsimons, R.B. & Hoh, J.F.Y. Embryonic and foetal myosins in human skeletal muscle: the presence of foetal myosins in Duchenne muscular dystrophy and infantile spinal muscular atrophy. J. Neurol. Sci. 52, 367−384 (1981). | Article | PubMed  | ISI | ChemPort |
48. Karsch-Mizrachi, I., Travis, M., Blau, H. & Leinwald, L.A. Expression and DNA sequence of a human embryonic skeletal muscle myosin heavy chain gene. Nuc. Acids. Res. 17, 6167−6179 (1989). | ChemPort |
49. McComas, A.J., Campbell, M.J. & Sica, R.E.P. Electrophysiological study of dystrophica myotonica. J. Neurol. Neurosurg. Psychiat. 34, 132−139 (1971). | PubMed  | ISI | ChemPort |
50. Belanger, A.Y. & McComas, A.J. Contractile properties of muscles in myotonic dystrphy. J. Neuro Neurosurg. Psychiat. 46, 625−631 (1983). | ISI | ChemPort |
51. Taylor, R.G., Abresch, R.T., Lieberman, J.S., Fowler, W.MN. & Entrikin, R.K. In vivo quantification of muscle contractility in humans: healthy subjects and patients with myotonic muscular dystrophy. Arch. Phys. Med. Rehabil. 73, 233−236 (1992). | Article | PubMed  | ISI | ChemPort |
52. Salvatori, S., Biral, D., Furlan, S. & O., M. Identification and localization of the myotonic dystrophy gene product in skeletal and cardiac muscles. Biochem. Biophys. Res. Commun. 203, 1365−1370 (1994). | Article | PubMed  | ISI | ChemPort |
53. Dunne, P.W., Ma, L., Casey, D.L., Harati, Y. & Epstein, H.F. Localization of myotonic dystrophy protein kinase in skeletal muscle and its alteration with disease. Cell Motility and the Cytoskeleton 33 1995).
54. Timchenko, L. et al. Full-length myotonin protein kinase (72 KDa) displays serine kinase activity. Proc. Natl. Acad. Sci. USA 92, 5366−5370 (1995). | PubMed  | ChemPort |
55. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. & Sweeny, H.L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA 90, 3710−3714 (1993). | PubMed  | ChemPort |
56. Dubowitz, V., Muscle Biopsy 2nd. ed. (W.B. Saunders, 1985).
57. Aleu, F.P. & Afifi, A.K. Ultrastructure of muscle in myotonic dystrophy. Am. J. Pathol. 45, 221−231. (1964). | PubMed  | ISI | ChemPort |
58. Johnson, A.G. Alteration of the Z lines and I-band myofilaments in human skeletal muscle. Arch Neuropathol (Berlin) 12, 218−226 (1969). | ChemPort |
59. Johnson, A.G. & Woolf, A.L. Abnormal sarcolemmal nuclei encountered in several cases of dystrophica myotonica. Acta neuropath. (Berl.) 12, 183−188 (1969). | ChemPort |
60. Fardeau, M. Ultrastructural lesions in progressive muscular dystrophies. A critical study of their specificity. In: J.N. Walton, N. Canal and G. Scarlata eds: Muscle Diseases, Amsterdam. Experta Medica, 98−108 (1970).
61. Schotland, D.L. An electron microscopic investigation of myotonic dystrophy. J. Neuropath. & Exper. Neurol. 29, 241−253 (1970). | ChemPort |
62. Bulfield, G., Siller, W.G., Wright, P.A. & Moore, K.J. X-chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 81, 1189−1192 (1984). | PubMed  | ChemPort |
63. Rastinjad, F. & Blau, H. Genetic complementation reveals a novel regulatory role for 3' untranslated region in growth and differentiation. Cell 72, 903−917 (1993). | PubMed  |
64. Wang, Y.-H., Amirhaeri, S., Kang, S., Wells, R.D. & Griffith, J.D. Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 265, 1709−1712 (1994). | PubMed  | ISI | ChemPort |
65. Wang, Y.-H. & Griffith, J. Expanded CTG triplet blocks from the myotonic dystrophy gene create the strongest known natural nucleosome positioning elements. Genomics 25, 570−573 (1995). | Article | PubMed  | ISI | ChemPort |
66. Boucher, C.A. et al. A novel homeodomain encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum. Mol. Genet. 4, 1919−1925 (1995). | PubMed  | ISI | ChemPort |
67. Shaw, D.J. et al. Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 18, 673−679 (1993). | PubMed  | ISI | ChemPort |
68. Tybulewicz, V.L.J., Crawford, C.E., Jackson, P.K., Bronson, R.T. & Mulligan, R.C. Neonatal lethality and lymhopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65, 1153−1163 (1991). | Article | PubMed  | ISI | ChemPort |
69. Mansour, S.L., Thomas, K.R. & Capecchi, M.R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem-cells: a general strategy for targeting mutations to nonselectable genes. Nature 336, 348−352 (1988). | Article | PubMed  | ISI | ChemPort |
70. Laird, R.W. et al. Simplified mammalian DNA isolation procedure. Nucl. Acids Res. 19, 4293 (1991). | PubMed  | ISI | ChemPort |
71. Hogan, B., Constantini, F. & Lacy, E. Manipulating the Mouse Embryo: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, 1986).
72. Davis, R.L., Weintraub, H. & Lassar, A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987−1000 (1987). | Article | PubMed  | ISI | ChemPort |
73. Braun, T.G. et al. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J. 8, 3617−3625 (1989). | PubMed  | ISI | ChemPort |
74. Braun, T., Buschhausen-Denker, G., Bober, E., Tannich, E. & Arnold, H.-H. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO. J. 8, 701−709 (1989). | PubMed  | ISI | ChemPort |
75. Rhodes, S.J. & Konieczny, S.F. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3, 2050−2061 (1989). | PubMed  | ISI | ChemPort |
76. Shackleford, G.M. & Varmus, H.E. Expression of the proto-oncogene int1 is restricted to post meiotic male germ cells and the neural tube of midgestational embryos. Cell 50, 89−95 (1987). | Article | PubMed  | ISI | ChemPort |
77. Close, K. Dynamic properties of mammalian skeletal muscle. Phys. Rev. 52, 129−197 (1972). | ISI |
78. Schiaffino, S., Gorza, L., Dones, I., Cornelio, F. & Sartore, S. Fetal myosin immunoreactivity in human dystrophic muscle. Muscle Nerve 9, 51−58 | PubMed  | ChemPort |

	Top

	Top